XENETIC BIOSCIENCES INC (XBIO:NASDAQ)
$3.56 0.18 (5.3254%)
Analysed XENETIC BIOSCIENCES INC (XBIO:NASDAQ) News Sources
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
13-03-2026
yahoo.com
Xenetic Biosciences: Q4 Earnings Snapshot
12-03-2026
yahoo.com
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
11-12-2025
yahoo.com
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
19-11-2025
yahoo.com
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
13-11-2025
yahoo.com
Xenetic Biosciences: Q3 Earnings Snapshot
12-11-2025
yahoo.com
Amneal Pharmaceuticals (AMRX) Beats Q3 Earnings and Revenue Estimates
30-10-2025
yahoo.com
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
10-10-2025
yahoo.com
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
13-08-2025
yahoo.com
Xenetic Biosciences (XBIO) Reports Q2 Loss, Misses Revenue Estimates
12-08-2025
yahoo.com
What is the current price of XENETIC BIOSCIENCES INC (XBIO:NASDAQ)?
The current price of XENETIC BIOSCIENCES INC (XBIO:NASDAQ) is $3.56.
XENETIC BIOSCIENCES INC (XBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of XENETIC BIOSCIENCES INC (XBIO:NASDAQ) since the previous trading day is $0.18.
XENETIC BIOSCIENCES INC (XBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of XENETIC BIOSCIENCES INC (XBIO:NASDAQ) since the previous trading day is 5.3254%.
What is the most recent average sentiment score for XENETIC BIOSCIENCES INC (XBIO:NASDAQ)?
The most recent average sentiment score for XENETIC BIOSCIENCES INC (XBIO:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for XENETIC BIOSCIENCES INC (XBIO:NASDAQ)?
The most recent sentiment for XENETIC BIOSCIENCES INC (XBIO:NASDAQ) is .
SEC-8K** Filing Available For XENETIC BIOSCIENCES INC (XBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.